Surgery Partners price to free cash flow SGRY

Market value divided by free cash flow over the last twelve months, since 2016.

Today, Oct 23, 2026: 11.0×
10-year median: 13.2×
Against its 10-year history: 44th; percentile: 0 is its lowest day, 100 its highest
10-year range: 3.4× to 249×
Peer median: 14.7×

Surgery Partners' price to free cash flow is 11.0× as of Oct 23, 2026.

That is below its ten-year median of 13.2×, close to the middle of its last ten years.

Over that time it ranged from 3.4× in Aug 2019 to 249× in Dec 2021.

The median for 10 hospital and care facility stocks of a similar size is 14.7×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	11.0×	7.6×	11.0×
2025	10.6×	10.2×	20.1×
2024	16.3×	14.7×	29.5×
2023	27.6×	22.6×	85.2×
2022	25.2×	23.1×	242×
2021	249×	7.2×	249×
2020	6.9×	3.7×	12.3×
2019	8.9×	3.4×	9.2×
2018	10.6×	8.4×	11.7×
2017	8.0×	5.3×	14.8×
2016	10.5×	8.9×	11.6×

Against its peers

Companies in Medical - Care Facilities nearest Surgery Partners' size, closest first, today.

Company	Price to free cash flow
SGRYSurgery Partners	11.0×
PGNYProgyny	12.5×
ADUSAddus HomeCare	14.7×
MDPediatrix Medical	10.4×
HCSGHealthcare Services	11.7×
ARDTArdent Health	5.7×
PRVAPrivia Health	n/m
PNTGPennant	42.2×
AVAHAveanna Healthcare	18.4×
USPHU S Physical Therapy	20.6×
OMDAOmada Health	51.0×
Peer median	14.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Surgery Partners

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.